Fingerprint
Dive into the research topics where Sanghoon Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights
Brodsky, A. L., Asare, A., Fellman, B., Anderson, K., Yao, J., Lee, S., Tran, H., Xu, X., Liu, J., Celestino, J., Hajek, R. A., Morgan, M. B., Mohammad, M., Soliman, P., Shafer, A., Sood, A. K., Bodurka, D., Fleming, N. D., Grinsfelder, M. O. & Milojevic, L. & 4 others, , Apr 2026, In: Clinical Cancer Research. 32, 7, p. 1234-1245 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples
Guo, S., Liu, X., Cheng, X., Jiang, Y., Ji, S., Liang, Q., Koval, A., Li, Y., Owen, L. A., Kim, I. K., Aparicio, A., Lee, S., Sood, A. K., Kopetz, S., Shen, J. P., Weinstein, J. N., DeAngelis, M. M., Chen, R. & Wang, W., Jan 2025, In: Genome Research. 35, 1, p. 147-161 15 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy (Nature, (2025), 644, 8076, (537-546), 10.1038/s41586-025-09203-8)
Dai, Y., Knisely, A., Yano, M., Dang, M., Hinchcliff, E. M., Lee, S., Welp, A., Chelvanambi, M., Lastrapes, M., Liu, H., Yuan, Z., Wang, C., Nie, H., Jean, S., Montaner, L. J., Hou, J., Patel, A., Patel, S., Fellman, B. & Yuan, Y. & 21 others, , Sep 25 2025, In: Nature. 645, 8082, p. E10Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Epigenetic modulation of BARD1 to enhance anti-VEGF therapy
Bayraktar, E., Rodriguez-Aguayo, C., Stur, E., Kumar, S., Mangala, L. S., Jennings, N. B., Bayram, N. N., Corvigno, S., Asare, A., Ivan, C., Kim, M. S., Vu, T. C., Hanjra, P., Kim, S., Ahumada, A. L., Wu, W., Lee, S., Szymanowska, A., Oztatlici, H. & Estecio, M. R. & 9 others, , Sep 16 2025, In: Cell Reports Medicine. 6, 9, 102329.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer
Corvigno, S., Yao, J., Asare, A., Zhao, L., Celestino, J., Hajek, R. A., Goette, E. A. A., Rogers, R. T., Montoya, R. N., Song, P., Zhang, Q. C., Song, X., Mohammad, M. M., Shaw, K. R., Zhang, J., Lu, K. H., Jazaeri, A. A., Westin, S. N., Sood, A. K. & Lee, S., 2025, In: Frontiers in Oncology. 15, 1538446.Research output: Contribution to journal › Article › peer-review
Open Access